SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as the community debates the delayed 80th clinical event in its pivotal REGAL trial, with bulls interpreting the extended duration as a sign of efficacy and bears questioning trial integrity. Investors are closely monitoring potential acquisition catalysts and institutional short-interest metrics while speculating on the company's path toward commercialization or a high-premium buyout.

Aurora Innovation, Inc. engages in the design and development of automobile hardware, software, and provision of data services. It offers the Aurora Driver which allows a vehicle to drive itself. The company was founded by Christopher Urmson, Sterling Anderson and James Andrew Bagnell in 2017 and is headquartered in Pittsburgh, PA.

Aurora Innovation Inc - Ordinary Shares - Class A

Aurora Innovation is experiencing significant momentum driven by growing commercial validation through partnerships like Volvo and FedEx, alongside aggressive volume and short-covering activity. The community is actively discussing the company's potential as a long-term leader in autonomous trucking, focusing on scaling infrastructure and overcoming industry-wide labor challenges.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is currently trending as investors weigh intense market speculation against recent technical consolidation, with the community actively debating the company's competitive standing and FAA certification progress. Discussion is heavily polarized between long-term proponents betting on its vertical integration and upcoming commercial launches, and skeptics focused on potential legal headwinds and near-term price volatility.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is seeing renewed investor interest driven by rising trading volume and community debates over its role in Japan's blockchain ecosystem, though skeptics remain focused on past price volatility and concerns regarding long-term utility. Despite polarized sentiment, the community is actively tracking technical support levels and speculating on potential institutional adoption in the IoT and data ownership sectors.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is capturing investor attention as the market shifts focus toward the future of real-world AI and autonomous transportation, though community sentiment remains divided between long-term optimism for eVTOL technology and frustration over the company's lack of recent technical milestones like piloted transition flights. Discussions are currently dominated by debates over institutional activity, including recent adjustments to holdings by major funds, and the company's progress toward regulatory certification ahead of high-profile global events.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is rallying as investors await critical Phase 3 VELA 52-week clinical data, which many anticipate will confirm the company's leading position in the Hidradenitis Suppurativa market. The community is heavily focused on the potential for a major valuation rerating or acquisition, with discussions centering on whether the upcoming trial results will trigger an M&A event or validate the asset's 'best-in-class' therapeutic potential.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing heightened volatility and intense debate among investors as community members weigh the stock's long-term potential in the voice AI sector against concerns over insider share disposals, acquisition-related dilution, and short-seller pressure. While bulls point to recent industry recognition as an AI leader and a growing backlog of enterprise contracts as signs of an impending reversal, others remain skeptical, focusing on the company's path to profitability and lack of immediate catalysts to spark a sustained rally.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is seeing intense debate as investors weigh the potential of its AI software against technical pressure and concerns about valuation multiples and sector rotation. The community remains deeply divided between long-term bulls who point to accelerating commercial and government contract adoption, and vocal bears who highlight recent technical weaknesses and speculative volatility.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is experiencing significant upward momentum as investors speculate on upcoming FDA peptide reviews and growth from new product integrations. The stock is currently a major focus for retail and institutional traders, with the community actively debating potential short-squeeze mechanics and the company's ability to maintain its recent price breakout.

FreeCast, Inc. operates an online video streaming platform. Its cloud entertainment platform comprises the largest aggregated library of free and pay-per-view video-on-demand, streaming channels, live events, radio stations, music videos and online games. The company was founded by William A. Mobley, Jr. on June 21, 2011 and is headquartered in Orlando, FL.

Freecast Inc - Ordinary Shares - Class A

Freecast Inc

Freecast Inc. is experiencing extreme volatility and intense retail interest driven by a strategic reseller agreement with Starlink Business, fueling a massive short squeeze momentum. While retail bulls are aggressively targeting a continued rally and celebrating significant gains, community discourse remains sharply polarized between those betting on further upside potential and skeptics warning of imminent dilution risks and weak fundamentals.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Innovaro, Inc. operates as an innovation solutions company. It is focused on delivering innovation solutions to its clients through a combination of software and associated services as well as information for strategic decision making. The company was founded in 1998 and is headquartered in Charlotte, NC.

Innovaro Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$0.0219
Prev Close	$0.0218
Open	$0.0185
Dividend Yield	0.00%
50-Day Moving Average	$0.0196
Beta	1.00
Avg. Volume	78,319.70
PE Ratio	0.00

52-Week High	$0.052
52-Week Low	$0.0016
Market Capitalization	$353,707.00
EPS (Annual)	$0.00
Price to Book	-312.86
Revenue Per Employee	$0.00

INNIInnovaro Inc.

Fundamentals

Feed

News

Sentiment

Fundamentals

Info

Latest INNI News